Linda Hendriks

1.6k total citations · 1 hit paper
19 papers, 1.3k citations indexed

About

Linda Hendriks is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Linda Hendriks has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Linda Hendriks's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Protein purification and stability (4 papers) and HER2/EGFR in Cancer Research (4 papers). Linda Hendriks is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Protein purification and stability (4 papers) and HER2/EGFR in Cancer Research (4 papers). Linda Hendriks collaborates with scholars based in Netherlands, Belgium and Switzerland. Linda Hendriks's co-authors include Jan C. M. van Hest, Peter Friedl, Floris L. van Delft, Samuel Schmidt, Floris P. J. T. Rutjes, Rinske P. Temming, Jan Dommerholt, Dirk J. Lefeber, Jeroen J. L. M. Cornelissen and Roeland J. M. Nolte and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Linda Hendriks

19 papers receiving 1.3k citations

Hit Papers

Readily Accessible Bicyclononynes for Bioorthogonal Label... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers

Linda Hendriks
Irwin Chen United States
Kaycie M. Deyle Switzerland
Vu Hong United States
Tetsuo Uno United States
Yu Heng Lau Australia
Jinzi J. Wu United States
Irwin Chen United States
Linda Hendriks
Citations per year, relative to Linda Hendriks Linda Hendriks (= 1×) peers Irwin Chen

Countries citing papers authored by Linda Hendriks

Since Specialization
Citations

This map shows the geographic impact of Linda Hendriks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Hendriks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Hendriks more than expected).

Fields of papers citing papers by Linda Hendriks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Hendriks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Hendriks. The network helps show where Linda Hendriks may publish in the future.

Co-authorship network of co-authors of Linda Hendriks

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Hendriks. A scholar is included among the top collaborators of Linda Hendriks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Hendriks. Linda Hendriks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Geuijen, Cecile, David Maussang, Tristan Gallenne, et al.. (2021). Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell. 39(8). 1163–1164. 2 indexed citations
2.
Geuijen, Cecile, Tristan Gallenne, Linda Hendriks, et al.. (2021). Abstract 957: Zenocutuzumab: An antibody that can overcome HER3 mediated HRG signalling in tumor cells by docking on HER2. Cancer Research. 81(13_Supplement). 957–957. 2 indexed citations
3.
Loo, Pieter Fokko van, Basav N. Hangalapura, Soley Thordardottir, et al.. (2019). MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis. Expert Opinion on Biological Therapy. 19(7). 721–733. 47 indexed citations
4.
Geuijen, Cecile, David Maussang, Tristan Gallenne, et al.. (2018). Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell. 33(5). 922–936.e10. 84 indexed citations
5.
Hendriks, Linda, et al.. (2017). A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1. Journal of Biological Chemistry. 292(35). 14706–14717. 71 indexed citations
6.
Hendriks, Linda, Tristan Gallenne, Robert P. Doornbos, et al.. (2017). Abstract 33: The binding mode of the bispecific anti-HER2xHER3 antibody MCLA-128 is responsible for its potent inhibition of HRG-driven tumorigenesis. Cancer Research. 77(13_Supplement). 33–33. 2 indexed citations
7.
Thompson, Natalie, Linda Hendriks, John de Kruif, Mark Throsby, & Albert J. R. Heck. (2013). Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry. mAbs. 6(1). 197–203. 34 indexed citations
8.
Rosati, Sara, Natalie Thompson, Arjan Barendregt, et al.. (2012). Qualitative and Semiquantitative Analysis of Composite Mixtures of Antibodies by Native Mass Spectrometry. Analytical Chemistry. 84(16). 7227–7232. 33 indexed citations
9.
Minten, Inge J., et al.. (2011). Metal‐Ion‐Induced Formation and Stabilization of Protein Cages Based on the Cowpea Chlorotic Mottle Virus. Small. 7(7). 911–919. 21 indexed citations
10.
Dommerholt, Jan, Samuel Schmidt, Rinske P. Temming, et al.. (2010). Readily Accessible Bicyclononynes for Bioorthogonal Labeling and Three‐Dimensional Imaging of Living Cells. Angewandte Chemie International Edition. 49(49). 9422–9425. 594 indexed citations breakdown →
11.
Dommerholt, Jan, Samuel Schmidt, Rinske P. Temming, et al.. (2010). Readily Accessible Bicyclononynes for Bioorthogonal Labeling and Three‐Dimensional Imaging of Living Cells. Angewandte Chemie. 122(49). 9612–9615. 132 indexed citations
12.
Lavigueur, Christine, J. Víctor García, Linda Hendriks, et al.. (2010). Thermoresponsive giant biohybrid amphiphiles. Polymer Chemistry. 2(2). 333–340. 55 indexed citations
13.
Minten, Inge J., Linda Hendriks, Roeland J. M. Nolte, & Jeroen J. L. M. Cornelissen. (2009). Controlled Encapsulation of Multiple Proteins in Virus Capsids. Journal of the American Chemical Society. 131(49). 17771–17773. 173 indexed citations
14.
Lambermon, Mark H. L., Linda Hendriks, Sanne Schoffelen, et al.. (2006). Assembly Strategies for Enzyme Immobilization. Polymer preprints. 47(2). 209–210. 1 indexed citations
15.
Üstün, Celalettin, et al.. (2002). Prolonged Partial Thromboplastin Time Without Bleeding History; Fletcher Factor Deficiency.. PubMed. 19(3). 417–9. 1 indexed citations
16.
Kuilman, M.E.M., R.F.M. Maas, Renger F. Witkamp, et al.. (1999). 17alpha-ethyl-5beta-estrane-3alpha, 17beta-diol, a biological marker for the abuse of norethandrolone and ethylestrenol in slaughter cattle. Journal of Chromatography B. 728. 217. 2 indexed citations
17.
Kuilman, M.E.M., R.F.M. Maas, Renger F. Witkamp, et al.. (1999). 17α-Ethyl-5β-estrane-3α,17β-diol, a biological marker for the abuse of norethandrolone and ethylestrenol in slaughter cattle. Journal of Chromatography B Biomedical Sciences and Applications. 728(2). 217–232. 6 indexed citations
18.
Hendriks, Linda, et al.. (1994). Screening for the illegal use of clostebol acetate in cattle by identification of its urinary metabolites. Veterinary Record. 134(8). 192–193. 10 indexed citations
19.
Missotten, Marc, et al.. (1994). Metabolites of 4-chlorotestosterone acetate in cattle urine as diagnostic markers for its illegal use. Journal of Chromatography B Biomedical Sciences and Applications. 654(1). 43–54. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026